Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea · Delayed Price · Currency is KRW 172,600
-500 (-0.29%)
At close: Jan 9, 2026
Daewoong Pharmaceutical Market Cap
Daewoong Pharmaceutical has a market cap or net worth of 1.99 trillion as of January 9, 2026. Its market cap has increased by 43.95% in one year.
Market Cap
1.99T
Enterprise Value
2.73T
Revenue
1.54T
Ranking
n/a
PE Ratio
21.31
Stock Price
172,600.00
Market Cap Chart
Since March 12, 2003, Daewoong Pharmaceutical's market cap has increased from 131.88B to 1.99T, an increase of 1,405.92%. That is a compound annual growth rate of 12.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.99T | 0.17% |
| Dec 30, 2025 | 1.98T | 36.31% |
| Dec 30, 2024 | 1.45T | 8.22% |
| Dec 28, 2023 | 1.34T | -23.40% |
| Dec 29, 2022 | 1.75T | 7.09% |
| Dec 30, 2021 | 1.64T | -7.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 87.26T |
| Celltrion | 46.60T |
| ALTEOGEN | 25.59T |
| ABL Bio | 11.88T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.46T |
| HLB Co., Ltd. | 6.66T |
| LigaChem Biosciences | 6.62T |